|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_ocn957318289 |
| 003 |
OCoLC |
| 005 |
20231120112129.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
160819s2016 enk ob 001 0 eng d |
| 040 |
|
|
|a IDEBK
|b eng
|e rda
|e pn
|c IDEBK
|d N$T
|d OPELS
|d YDX
|d EBLCP
|d OCLCF
|d QCL
|d OCLCA
|d S4S
|d OCLCQ
|d DEBBG
|d U3W
|d MERUC
|d OCLCO
|d SNK
|d OCLCO
|d CHVBK
|d OCLCQ
|d OCLCO
|d FEM
|d UKMGB
|d OCLCQ
|d OCLCO
|d OCLCA
|d S2H
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 015 |
|
|
|a GBB6B4645
|2 bnb
|
| 016 |
7 |
|
|a 017978497
|2 Uk
|
| 019 |
|
|
|a 956988807
|a 957606408
|a 960737212
|a 960835830
|a 963347013
|a 964568252
|a 965422589
|a 968984791
|
| 020 |
|
|
|a 0128033908
|q (electronic bk.)
|
| 020 |
|
|
|a 9780128033906
|q (electronic bk.)
|
| 020 |
|
|
|z 0128033762
|
| 020 |
|
|
|z 9780128033760
|
| 035 |
|
|
|a (OCoLC)957318289
|z (OCoLC)956988807
|z (OCoLC)957606408
|z (OCoLC)960737212
|z (OCoLC)960835830
|z (OCoLC)963347013
|z (OCoLC)964568252
|z (OCoLC)965422589
|z (OCoLC)968984791
|
| 050 |
|
4 |
|a RM333.5
|
| 060 |
|
4 |
|a QV 77.9
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615.7882
|2 23
|
| 245 |
0 |
0 |
|a Life-threatening effects of antipsychotic drugs /
|c edited by Peter Manu, Robert J. Flanagan, Kathlyn J. Ronaldson.
|
| 264 |
|
1 |
|a [London] :
|b Elsevier :
|b Academic Press,
|c 2016.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a <P><b>Part I: Cardiovascular Adverse Effects of Antipsychotic Drugs</b></p> <p>Chapter 1 -- Sudden Cardiac Death and Ventricular Arrhythmias</p> <p>Peter Manu, Anca Dan and Gheorghe-Andrei Dan</p> <p>Chapter 2 -- Myocarditis and Cardiomyopathy</p> <p>Kathlyn J. Ronaldson</p> <p>Chapter 3 -- Pulmonary Embolism</p> <p>Peter Manu, Christopher Hohman, James F. Barrecchia, and Matisyahu Shulman</p> <p>Chapter 4 -- Orthostatic Hypotension</p> <p>James J. Gugger and Megan J. Ehret</p> <p><b>Part II: Hematological Complications of Treatment With Antipsychotic Drugs</b></p> <p><b></b></p> <p>Chapter 5 -- Severe Neutropenia and Agranulocytosis</p> <p>John Lally and Robert J. Flanagan</p> <p><b>Part III: Antipsychotic-Related Pathology of the Digestive System</b></p> <p><b></b></p> <p>Chapter 6 -- Gastrointestinal Hypomotility and Dysphagia</p> <p>Robert J. Flanagan and Kathlyn J. Ronaldson</p> <p>Chapter 7 -- Liver Failure</p> <p>Katie F.M. Marwick</p> <p>8. Pancreatitis</p> <p>Peter Manu, Matisyahu Shulman and Kathlyn J. Ronaldson</p> <p><b>Part IV: Major Neurological and Neuromuscular Adverse Effects of Antipsychotic Drugs</b></p> <p><b></b></p> <p>Chapter 9 -- Seizures</p> <p>Tilman Steinert and Walter Fr�oscher</p> <p>Chapter 10 -- Neuroleptic Malignant Syndrome</p> <p>Julie Langan Martin and Daniel J. Martin</p> <p>Chapter 11 -- Heat Stroke and Rhabdomyolysis</p> <p>Kathlyn J. Ronaldson</p> <p><b>Part V: Metabolic Complications of Antipsychotic Drug Treatment</b></p> <p><b></b></p> <p>Chapter 12 -- Type 2 Diabetes Mellitus</p> <p>Davy Vancampfort, Richard I.G. Holt, Brendon Stubbs, Marc De Hert, Katherine Samaras and Alex J. Mitchell</p> <p><b>Part VI: Other Life-Threatening Effects of Antipsychotic Drugs</b></p> <p><b></b></p> <p>Chapter 13 -- Interstitial Nephritis and Interstitial Lung Disease</p> <p>Kathlyn J. Ronaldson</p> <p><b>Part VII: Clinical and Forensic Challenges in the Use of Antipsychotic Drugs</b></p> <p><b></b></p> <p>Chapter 14 -- The Benefits of Antipsychotic Drugs: Symptom Control and Improved Quality of Life</p> <p>Jian-Ping Zhang</p> <p>Chapter 15 -- Antipsychotic-Related Mortality: Risk and Strategy for Improved Clinical Management</p> <p>Dan Cohen</p> <p>Chapter 16 -- Forensic Investigation of Antipsychotic-Related Deaths</p> <p>Robert J. Flanagan and Peter Manu</p>
|
| 650 |
|
0 |
|a Antipsychotic drugs
|x Side effects.
|
| 650 |
|
2 |
|a Antipsychotic Agents
|x adverse effects
|0 (DNLM)D014150Q000009
|
| 650 |
|
6 |
|a Neuroleptiques
|x Effets secondaires.
|0 (CaQQLa)201-0197585
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Antipsychotic drugs
|x Side effects
|2 fast
|0 (OCoLC)fst00810673
|
| 700 |
1 |
|
|a Manu, Peter,
|d 1947-
|
| 700 |
1 |
|
|a Flanagan, Robert J.
|
| 700 |
1 |
|
|a Ronaldson, Kathlyn J.
|
| 776 |
0 |
8 |
|i Print version:
|t Life-threatening effects of antipsychotic drugs.
|d [London] : Elsevier : Academic Press, 2016
|z 0128033762
|z 9780128033760
|w (OCoLC)946605523
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128033760
|z Texto completo
|
